[1]
|
Wu, Y., Ding, Y., Tanaka, Y. and Zhang, W. (2014) Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention. International Journal of Medical Sciences, 11, 1185-200.
https://doi.org/10.7150/ijms.10001
|
[2]
|
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Di-abetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federa-tion Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[3]
|
Gutiérrez-Salmerón, M., Lucena, S.R., Chocarro-Calvo, A., et al. (2021) Remodelling of Colorectal Cancer Cell Signalling by Microbiota and Immunity in Diabetes. Endocrine-Related Cancer, 28, R173-R190.
https://doi.org/10.1530/ERC-20-0315
|
[4]
|
Chen, D., Jin, D., Huang, S., Wu, J., Xu, M., Liu, T., Dong, W., Liu, X., Wang, S., Zhong, W., et al. (2020) Clostridium butyricum, a Butyrate-Producing Probiotic, Inhibits Intestinal Tumor Development through Modulating Wnt Signaling and Gut Microbiota. Cancer Letters, 469, 456-467. https://doi.org/10.1016/j.canlet.2019.11.019
|
[5]
|
Amyot, J., Semache, M., Ferdaoussi, M., Fontés, G. and Poitout, V. (2012) Lipopolysaccharides Impair Insulin Gene Expression in Isolated Islets of Langerhans via Toll-Like Receptor-4 and NF-κB Signalling. PLOS ONE, 7, e36200.
https://doi.org/10.1371/journal.pone.0036200
|
[6]
|
杨玥, 吴晓康. 中医药干预肠道菌群防治糖尿病的研究进展[J]. 中国实验方剂学杂志, 2021, 27(7): 219-227.
|
[7]
|
Pitt, J.M., Vétizou, M., Gomperts Boneca, I., et al. (2016) En-hancing the Clinical Coverage and Anticancer Efficacy of Immune Checkpoint Blockade through Manipulation of the Gut Microbiota. OncoImmunology, 6, e1132137.
https://doi.org/10.1080/2162402X.2015.1132137
|
[8]
|
Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H. and Kim, D.-H. (2012) High Fat Diet-Signaling Pathway. PLOS ONE, 7, e47713. https://doi.org/10.1371/journal.pone.0047713
|
[9]
|
Wisniewski, P.J., Dowden, R.A. and Campbell, S.C. (2019) Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota. Nutrients, 11, Article No. 117. https://doi.org/10.3390/nu11010117
|
[10]
|
Jia, L., Vianna, C., Fukuda, M., et al. (2014) Hepatocyte Toll-Like Re-ceptor 4 Regulates Obesity-Induced Inflammation and Insulin Resistance. Nature Communications, 5, Article No. 3878. https://doi.org/10.1038/ncomms4878
|
[11]
|
陈洁, 姜虹. TLR4 信号通路与炎性反应[J]. 医学综述, 2009, 15(19): 2902-2904.
|
[12]
|
Ryu, J.-K., Kim, S.J., Rah, S.-H., et al. (2017) Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer. Immunity, 46, 38-50.
https://doi.org/10.1016/j.immuni.2016.11.007
|
[13]
|
Akash, M.S.H., Rehman, K. and Liaqat, A. (2018) Tumor Ne-crosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus. Journal of Cellular Biochemistry, 119, 105-110.
https://doi.org/10.1002/jcb.26174
|
[14]
|
Ueki, K., Kondo, T. and Kahn, C.R. (2004) Suppressor of Cytokine Signal-ing 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Re-ceptor Substrate Proteins by Discrete Mechanisms. Molecular and Cellular Biology, 24, 5434-5446. https://doi.org/10.1128/MCB.24.12.5434-5446.2004
|
[15]
|
Ahmed, B., Sultana, R. and Greene, M.W. (2021) Adi-pose Tissue and Insulin Resistance in Obese. Biomedicine & Pharmacotherapy, 137, Article ID: 111315. https://doi.org/10.1016/j.biopha.2021.111315
|
[16]
|
Khondkaryan, L., Margaryan, S., Poghosyan, D., et al. (2018) Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus. International Journal of Inflammation, 2018, Ar-ticle ID: 2157434.
https://doi.org/10.1155/2018/2157434
|
[17]
|
Huang, J., Guan, B., Lin, L., et al. (2021) Improvement of Intestinal Barrier Function, Gut Microbiota, and Metabolic Endotoxemia in Type 2 Diabetes Rats by Curcumin. Bioengineered, 12, 11947-11958.
https://doi.org/10.1080/21655979.2021.2009322
|
[18]
|
Gu, W., Wang, Y., Zeng, L., et al. (2020) Polysaccharides From Polygonatum kingianum Improve Glucose and Lipid Metabolism in Rats Fed a High Fat Diet. Biomedicine & Pharmacotherapy, 125, Article ID: 109910.
https://doi.org/10.1016/j.biopha.2020.109910
|
[19]
|
Zhang, W., Xu, J.-H., Yu, T. and Chen, Q.-K. (2019) Effects of Berberine and Metformin on Intestinal Inflammation and Gut Microbiome Composition in db/db Mice. Biomedicine & Pharmacotherapy, 118, Article ID: 109131.
https://doi.org/10.1016/j.biopha.2019.109131
|
[20]
|
Duan, Y., Dai, H., An, Y., et al. (2022) Mulberry Leaf Flavo-noids Inhibit Liver Inflammation in Type 2 Diabetes Rats by Regulating TLR4/MyD88/NF-κB Signaling Pathway. Evi-dence-Based Complementary and Alternative Medicine, 2022, Article ID: 3354062. https://doi.org/10.1155/2022/3354062
|
[21]
|
朱金华, 周军, 万红娇, 等. 黄连温胆汤对 2 型糖尿病模型大鼠细胞因子及TLR4、NF-κB变化的影响[J]. 中药药理与临床, 2021, 37(3): 6-11.
|
[22]
|
章常华, 马广强, 邓永兵, 等. 葛根芩连汤对KK-Ay糖尿病小鼠血浆中LPS、TNF-α、IL-6及肠道菌群的影响[J]. 中草药, 2017, 48(8): 1611-1616.
|
[23]
|
吴帆. 乌梅丸调节肠道菌群对2型糖尿病的干预作用及机制研究[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2019.
|
[24]
|
陈玲玲, 张思为, 李董平, 陈伊莉. 薏苡附子败酱散对糖尿病小鼠炎症因子及肠道菌群的影响[J]. 陕西中医, 2018, 39(4): 415-418.
|
[25]
|
池杨峰, 刘爽, 黄洁波, 等. 黄芪汤通过TLR4/NF-κB信号通路改善糖尿病肾病大鼠炎症反应的研究[J]. 临床肾脏病杂志, 2022, 22(1): 39-45.
|
[26]
|
李志俊. 黄芪汤通过抑制TLR4/NF-κB信号通路改善糖尿病肾病大鼠的炎症反应[D]: [硕士学位论文]. 上海: 上海中医药大学, 2019. https://doi.org/10.27320/d.cnki.gszyu.2019.000774
|
[27]
|
张岩. 泻火解毒养阴方对2型糖尿病小鼠LPS/TLR4/NF-κB信号通路的影响[D]: [硕士学位论文]. 济南: 山东中医药大学, 2020.
|
[28]
|
Li, M., Ding, L., Hu, Y.-L., et al. (2021) Herbal Formula LLKL Ameliorates Hyperglycaemia, Modulates the Gut Microbiota and Regulates the Gut-Liver Axis in Zucker Diabetic Fatty Rats. Journal of Cellular and Molecular Medicine, 25, 367-382. https://doi.org/10.1111/jcmm.16084
|
[29]
|
刘文娟, 乐世俊, 姬玉洁, 等. 中药多糖调节肠道菌群治疗2型糖尿病研究进展[J]. 陕西中医药大学学报, 2023, 46(2): 36-42.
|